rs34083643

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBA1

The NM_030665.4(RAI1):​c.840delG​(p.Gln280HisfsTer84) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q280Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.38 ( 11070 hom., cov: 0)
Exomes 𝑓: 0.33 ( 48739 hom. )

Consequence

RAI1
NM_030665.4 frameshift

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.466

Publications

13 publications found
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]
RAI1 Gene-Disease associations (from GenCC):
  • Smith-Magenis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Potocki-Lupski syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BP6
Variant 17-17793787-AG-A is Benign according to our data. Variant chr17-17793787-AG-A is described in ClinVar as [Benign]. Clinvar id is 587783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.822 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAI1NM_030665.4 linkc.840delG p.Gln280HisfsTer84 frameshift_variant Exon 3 of 6 ENST00000353383.6 NP_109590.3 Q7Z5J4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAI1ENST00000353383.6 linkc.840delG p.Gln280HisfsTer84 frameshift_variant Exon 3 of 6 1 NM_030665.4 ENSP00000323074.4 Q7Z5J4-1
RAI1ENST00000395774.1 linkc.840delG p.Gln280HisfsTer84 frameshift_variant Exon 2 of 2 2 ENSP00000379120.1 A8MXE8

Frequencies

GnomAD3 genomes
AF:
0.377
AC:
54845
AN:
145638
Hom.:
11075
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.350
Gnomad AMI
AF:
0.398
Gnomad AMR
AF:
0.478
Gnomad ASJ
AF:
0.356
Gnomad EAS
AF:
0.843
Gnomad SAS
AF:
0.702
Gnomad FIN
AF:
0.352
Gnomad MID
AF:
0.332
Gnomad NFE
AF:
0.314
Gnomad OTH
AF:
0.381
GnomAD2 exomes
AF:
0.237
AC:
42962
AN:
181254
AF XY:
0.241
show subpopulations
Gnomad AFR exome
AF:
0.169
Gnomad AMR exome
AF:
0.356
Gnomad ASJ exome
AF:
0.178
Gnomad EAS exome
AF:
0.585
Gnomad FIN exome
AF:
0.111
Gnomad NFE exome
AF:
0.144
Gnomad OTH exome
AF:
0.194
GnomAD4 exome
AF:
0.326
AC:
445687
AN:
1368702
Hom.:
48739
Cov.:
0
AF XY:
0.332
AC XY:
226114
AN XY:
681328
show subpopulations
African (AFR)
AF:
0.345
AC:
10684
AN:
30970
American (AMR)
AF:
0.490
AC:
20902
AN:
42638
Ashkenazi Jewish (ASJ)
AF:
0.330
AC:
7680
AN:
23274
East Asian (EAS)
AF:
0.645
AC:
24105
AN:
37360
South Asian (SAS)
AF:
0.552
AC:
45960
AN:
83242
European-Finnish (FIN)
AF:
0.315
AC:
14835
AN:
47092
Middle Eastern (MID)
AF:
0.374
AC:
1989
AN:
5322
European-Non Finnish (NFE)
AF:
0.288
AC:
299881
AN:
1042738
Other (OTH)
AF:
0.350
AC:
19651
AN:
56066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
15118
30236
45355
60473
75591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10970
21940
32910
43880
54850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.376
AC:
54861
AN:
145752
Hom.:
11070
Cov.:
0
AF XY:
0.389
AC XY:
27738
AN XY:
71326
show subpopulations
African (AFR)
AF:
0.350
AC:
14232
AN:
40690
American (AMR)
AF:
0.478
AC:
7000
AN:
14646
Ashkenazi Jewish (ASJ)
AF:
0.356
AC:
1105
AN:
3104
East Asian (EAS)
AF:
0.843
AC:
4257
AN:
5048
South Asian (SAS)
AF:
0.701
AC:
3353
AN:
4782
European-Finnish (FIN)
AF:
0.352
AC:
3458
AN:
9826
Middle Eastern (MID)
AF:
0.326
AC:
90
AN:
276
European-Non Finnish (NFE)
AF:
0.314
AC:
20263
AN:
64512
Other (OTH)
AF:
0.379
AC:
751
AN:
1984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1716
3432
5147
6863
8579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000541
Hom.:
2

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 22, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 29, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Smith-Magenis syndrome Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.47
Mutation Taster
=144/56
disease causing (fs/PTC)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34083643; hg19: chr17-17697101; COSMIC: COSV55389171; COSMIC: COSV55389171; API